Average change of member stocks, by theme · descending
Gene Therapy & Genomics
+20.2%
Microbiome
+13.4%
Cancer Immunotherapy
+9.6%
Lithium
+8.5%
Pharma
+6.8%
OLED Displays
+5.2%
Rare Earths & Rare Metals
+5.0%
Biosimilars
+3.8%
Theme leaders · recent trend
The line is the trend; the end-point colour is the last trading day's direction. Stocks without enough price history show as -
Theme
Leader
Change
Trend
Gene Therapy & Genomics
CJ Bioscience
+29.87%
Microbiome
CJ Bioscience
+29.87%
Cancer Immunotherapy
MedPacto
+29.79%
Lithium
Aptn
+29.91%
Pharma
Theragen Etex
+18.96%
OLED Displays
Shindo Eng. Lab
+7.25%
Rare Earths & Rare Metals
Novatech
+7.76%
Biosimilars
SunBio
+4.31%
On 2023-04-05, biotech dominated the session’s strong themes. Gene Therapy & Genomics led with an average change of 20.23%, and all 9 of its stocks closed higher.
The theme returned after a gap of 1756 days, led by CJ Bioscience at 29.87%. The same stock also led Microbiome, which averaged 13.42% amid news of government investment.
Outside biotech, Lithium rose by an average of 8.49%, with Aptn up 29.91%. Cancer Immunotherapy stretched its streak to 2 days, led by MedPacto at 29.79%.
Pharma, Biosimilars and Cancer Immunotherapy have each been strong for 2 days in a row. Whether these runs continue will show how broad the bio sector’s strength is.
In Lithium, one headline reported a warning from brokerages after back-to-back limit-up moves, and another reported a drop in lithium prices. Next, watch how the theme responds to that news.